Track market-moving stories before they get noisy

LONDON & SANTA CLARA, Calif.--(BUSINESS WIRE)--ServiceNow (NYSE: NOW), the AI control tower for business reinvention, today announced that Experian, the global data and technology company, and strategic partner, is significantly expanding its deployment of the ServiceNow AI Platform to drive enterprise-wide AI-led transformation. As a long-standing ServiceNow customer, Experian is leveraging agentic AI workflows to automate intelligence at scale, improve operational efficiency and deliver AI-fi.

HomeStock IdeasLong IdeasTech 

SummaryBroadcom Inc. delivered a record Q2 FY26 with 47.9% YoY top line growth, driven by explosive AI semiconductor demand.Robust momentum in AVGO's AI silicon business, which now comprises 49% of consolidated revenue, and an elevated backlog should support top line growth through FY26.Operating leverage is likely to keep margins strong over the coming quarters despite continued pressure from high R&D.I maintain a BUY rating on AVGO, citing attractive valuation, a leading market position, and demand visibility from multi-year AI customer commitments. Sundry Photography/iStock Editorial via Getty Images

The Thesis The leading North American AI semiconductor company, Broadcom Inc. (AVGO), exited the first half of FY26 with strong momentum, delivering robust growth across its top line and bottom line in

1.32K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in AVGO over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

SEGRO PLC (LSE:SGRO) shares jumped 7% to 957p in early trading on Thursday after the board of the warehouse developer said it "would be minded" to recommend the "best and final" takeover proposal made by Prologis Inc (NYSE:PLD), after the US logistics property group raised its offer and committed to a secondary London listing.

Prologis offered 0.092 new shares for each Segro share, alongside a partial cash alternative of up to £3.5 billion. Based on Prologis's closing price on Tuesday, the proposal valued Segro shares at 1,031.7p each and the company at around £14 billion.

Under the offer, Segro shareholders would also retain the property group's final dividend of up to 22.56p per share, taking the total potential value to 1,054.3p. They would additionally be entitled to an interim dividend of up to 10.14p.

The revised terms represent a 9.5% improvement on Prologis's initial approach and a 39% premium to Segro's undisturbed share price.

On Monday, Segro had rejected a third proposal worth 993p per share, which led Prologis to accuse the company's board of relying on an "aspirational valuation built on unrealistic assumptions", before raising its bid for a fourth time.

Following further talks on Wednesday, Prologis has now contractually agreed to establish a secondary listing of its shares on the London Stock Exchange by the completion of any deal.

Segro's board said it had unanimously concluded that the latest financial terms were at a level it would recommend, subject to due diligence and agreement on the remaining conditions.

The takeover deadline for Prologis to announce a firm offer has been extended from Thursday to 5pm on 12 August.

Broker Panmure Liberum said: "We do not view paying shareholders with their own dividends as an increase in offer value, but this appears to be an increasingly common feature of public takeover negotiations."

Even including the retained dividend, the implied value remains below the broker's 1,300p target price and below both its assessment and SEGRO's own assessment of the value embedded in its development pipeline. 

However, the broker said that the commitment to establish a London secondary listing "is a meaningful development".

"The board's willingness to recommend materially increases the probability of a transaction completing on broadly these terms."

Chinese carmakers spent the past decade replacing gasoline engines with batteries. The next will be about integrating cars with robotics, XPeng's chief executive says.

Posted by Defense World Staff on Jul 23rd, 2026

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-three ratings firms that are covering the company, MarketBeat.com reports. Eight equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $440.9048.

A number of brokerages have issued reports on ELV. Mizuho upped their target price on Elevance Health from $435.00 to $465.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Truist Financial lifted their price target on Elevance Health from $450.00 to $475.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. The Goldman Sachs Group restated a “neutral” rating and set a $395.00 price target on shares of Elevance Health in a report on Thursday, July 16th. Raymond James Financial set a $450.00 price objective on Elevance Health in a research note on Tuesday, July 7th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Elevance Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $363.00 to $498.00 in a report on Wednesday, May 20th.

View Our Latest Stock Report on Elevance Health

Insider Activity In other news, Director Robert L. Dixon, Jr. sold 151 shares of Elevance Health stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $401.77, for a total transaction of $60,667.27. Following the transaction, the director owned 10,734 shares in the company, valued at approximately $4,312,599.18. The trade was a 1.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.34% of the company’s stock.

Institutional Inflows and Outflows Several large investors have recently bought and sold shares of the stock. Sei Investments Co. lifted its stake in shares of Elevance Health by 7.7% in the second quarter. Sei Investments Co. now owns 163,668 shares of the company’s stock worth $63,666,000 after acquiring an additional 11,745 shares during the period. Glenview Trust co increased its position in Elevance Health by 41.5% during the 2nd quarter. Glenview Trust co now owns 1,619 shares of the company’s stock valued at $630,000 after purchasing an additional 475 shares during the period. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main increased its position in Elevance Health by 6.9% during the 2nd quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 65,945 shares of the company’s stock valued at $25,650,000 after purchasing an additional 4,272 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Elevance Health by 5.0% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 42,371 shares of the company’s stock worth $16,478,000 after purchasing an additional 2,012 shares during the last quarter. Finally, Quantinno Capital Management LP raised its holdings in Elevance Health by 111.8% during the 2nd quarter. Quantinno Capital Management LP now owns 43,911 shares of the company’s stock worth $17,080,000 after purchasing an additional 23,180 shares during the last quarter. 89.24% of the stock is owned by institutional investors.

Elevance Health Stock Down 1.1% ELV stock opened at $389.29 on Thursday. Elevance Health has a 12 month low of $273.71 and a 12 month high of $436.24. The company has a current ratio of 1.52, a quick ratio of 1.52 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $84.42 billion, a P/E ratio of 17.30, a price-to-earnings-growth ratio of 2.26 and a beta of 0.67. The firm has a 50-day moving average price of $399.36 and a 200-day moving average price of $356.20.

Elevance Health (NYSE:ELV – Get Free Report) last announced its quarterly earnings results on Wednesday, July 15th. The company reported $7.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.21 by $1.24. Elevance Health had a net margin of 2.47% and a return on equity of 14.64%. The company had revenue of $49.83 billion during the quarter, compared to the consensus estimate of $48.88 billion. During the same period in the prior year, the business earned $8.84 earnings per share. The company’s revenue for the quarter was up .8% compared to the same quarter last year. As a group, equities research analysts anticipate that Elevance Health will post 27.08 EPS for the current fiscal year.

Elevance Health Dividend Announcement The firm also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Thursday, September 10th will be given a $1.72 dividend. This represents a $6.88 annualized dividend and a yield of 1.8%. The ex-dividend date is Thursday, September 10th. Elevance Health’s dividend payout ratio is 30.58%.

About Elevance Health (Get Free Report)

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.

Further Reading Five stocks we like better than Elevance Health Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAnalyzing Elauwit Connection (NASDAQ:ELWT) and TG-17 (NASDAQ:OBAI)

NEXT HEADLINE »Vulcan Materials Company (NYSE:VMC) Receives Consensus Rating of “Moderate Buy” from Analysts

Vývoj měnových párů: EUR/CZK 24,2

Posted by Defense World Staff on Jul 23rd, 2026

Cinemark (NYSE:CNK – Get Free Report) will likely be releasing its Q2 2026 results before the market opens on Thursday, July 30th. Analysts expect Cinemark to post earnings of $0.99 per share and revenue of $1.0279 billion for the quarter. Investors may review the information on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, July 30, 2026 at 8:30 AM ET.

Cinemark (NYSE:CNK – Get Free Report) last issued its quarterly earnings results on Friday, May 1st. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.01). Cinemark had a net margin of 5.31% and a return on equity of 41.31%. The business had revenue of $643.10 million during the quarter, compared to analyst estimates of $632.74 million. During the same period in the prior year, the business posted ($0.32) earnings per share. The company’s revenue for the quarter was up 18.9% compared to the same quarter last year. On average, analysts expect Cinemark to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Cinemark Price Performance NYSE CNK opened at $32.24 on Thursday. Cinemark has a twelve month low of $21.60 and a twelve month high of $34.73. The company has a debt-to-equity ratio of 5.03, a quick ratio of 0.58 and a current ratio of 0.62. The stock has a market capitalization of $3.77 billion, a PE ratio of 28.53 and a beta of 0.98. The stock has a 50-day simple moving average of $30.45 and a 200 day simple moving average of $27.98.

Cinemark Dividend Announcement The firm also recently announced a quarterly dividend, which was paid on Thursday, June 11th. Shareholders of record on Thursday, May 28th were issued a $0.09 dividend. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $0.36 dividend on an annualized basis and a yield of 1.1%. Cinemark’s dividend payout ratio (DPR) is 31.86%.

Hedge Funds Weigh In On Cinemark Large investors have recently added to or reduced their stakes in the company. Mercer Global Advisors Inc. ADV grew its holdings in shares of Cinemark by 17.8% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 17,683 shares of the company’s stock worth $411,000 after purchasing an additional 2,674 shares in the last quarter. Delta Global Management LP increased its position in shares of Cinemark by 2.6% during the fourth quarter. Delta Global Management LP now owns 92,928 shares of the company’s stock valued at $2,160,000 after purchasing an additional 2,381 shares during the period. XTX Topco Ltd raised its stake in shares of Cinemark by 1,056.3% in the fourth quarter. XTX Topco Ltd now owns 105,383 shares of the company’s stock valued at $2,449,000 after purchasing an additional 96,269 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Cinemark by 8.4% in the fourth quarter. Wellington Management Group LLP now owns 9,536,900 shares of the company’s stock valued at $221,638,000 after purchasing an additional 742,307 shares in the last quarter. Finally, Sora Investors LLC acquired a new position in shares of Cinemark in the fourth quarter valued at $1,234,000.

Wall Street Analysts Forecast Growth CNK has been the subject of a number of research analyst reports. Benchmark upped their price target on Cinemark from $35.00 to $37.00 and gave the stock a “buy” rating in a report on Wednesday, June 17th. Wall Street Zen upgraded shares of Cinemark from a “hold” rating to a “buy” rating in a research note on Sunday, May 31st. Wells Fargo & Company reaffirmed an “equal weight” rating and set a $31.00 target price (down from $36.00) on shares of Cinemark in a research report on Thursday, July 16th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cinemark in a research note on Wednesday, June 24th. Finally, Barrington Research reissued an “outperform” rating and issued a $36.00 price target on shares of Cinemark in a report on Monday, May 4th. Seven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $34.58.

Check Out Our Latest Report on Cinemark

Cinemark Company Profile (Get Free Report)

Cinemark Holdings, Inc (NYSE: CNK) is a leading theatrical exhibitor that acquires, develops and operates motion picture theatres under the Cinemark® brand in the United States and Latin America. The company’s core business involves the presentation of first-run feature films coupled with an array of in‐theatre services, including concessions, premium auditoriums and loyalty programs. Cinemark’s exhibition portfolio encompasses both corporate‐owned and franchised complexes, offering moviegoers a range of experiences from standard screens to large‐format halls.

The company’s product offerings extend beyond ticket sales to include an assortment of concession items, such as popcorn, fountain beverages, candy and specialty snacks, as well as bar and lounge concepts in select locations.

Recommended Stories Five stocks we like better than Cinemark Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Cinemark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEGildan Activewear (GIL) to Release Earnings on Thursday

NEXT HEADLINE »Trisura Group (TRRSF) Projected to Announce Earnings on Thursday

Posted by Defense World Staff on Jul 23rd, 2026

California Water Service Group (NYSE:CWT – Get Free Report) is projected to post its Q2 2026 results before the market opens on Thursday, July 30th. Analysts expect the company to announce earnings of $0.79 per share and revenue of $283.50 million for the quarter. Interested persons can check the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, July 30, 2026 at 11:00 AM ET.

California Water Service Group (NYSE:CWT – Get Free Report) last posted its earnings results on Thursday, April 30th. The utilities provider reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.18). The company had revenue of $214.57 million during the quarter, compared to the consensus estimate of $210.27 million. California Water Service Group had a return on equity of 7.06% and a net margin of 11.77%.The company’s revenue for the quarter was up 5.2% on a year-over-year basis. During the same period last year, the firm posted $0.22 EPS. On average, analysts expect California Water Service Group to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

California Water Service Group Price Performance Shares of CWT opened at $51.02 on Thursday. The firm has a fifty day simple moving average of $46.78 and a two-hundred day simple moving average of $45.62. The firm has a market cap of $3.05 billion, a PE ratio of 25.51, a P/E/G ratio of 1.86 and a beta of 0.51. The company has a current ratio of 0.69, a quick ratio of 0.65 and a debt-to-equity ratio of 0.87. California Water Service Group has a 1-year low of $41.29 and a 1-year high of $52.51.

California Water Service Group Dividend Announcement The company also recently disclosed a quarterly dividend, which was paid on Friday, May 22nd. Investors of record on Monday, May 11th were issued a $0.335 dividend. The ex-dividend date of this dividend was Monday, May 11th. This represents a $1.34 annualized dividend and a dividend yield of 2.6%. California Water Service Group’s payout ratio is presently 67.00%.

Wall Street Analysts Forecast Growth A number of research firms recently commented on CWT. Wall Street Zen upgraded California Water Service Group from a “sell” rating to a “hold” rating in a research report on Saturday, July 18th. Weiss Ratings raised California Water Service Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, June 12th. Finally, Robert W. Baird set a $54.00 price target on California Water Service Group in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, California Water Service Group presently has a consensus rating of “Moderate Buy” and an average target price of $54.50.

Get Our Latest Stock Report on California Water Service Group

Insider Activity at California Water Service Group In related news, Director Thomas M. Krummel sold 3,700 shares of California Water Service Group stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $43.30, for a total transaction of $160,210.00. Following the transaction, the director directly owned 23,805 shares in the company, valued at approximately $1,030,756.50. The trade was a 13.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Lester A. Snow sold 1,100 shares of the business’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $44.00, for a total value of $48,400.00. Following the sale, the director directly owned 18,316 shares of the company’s stock, valued at $805,904. This represents a 5.67% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.78% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows Several institutional investors have recently made changes to their positions in CWT. Algert Global LLC raised its stake in California Water Service Group by 17.9% during the 3rd quarter. Algert Global LLC now owns 6,257 shares of the utilities provider’s stock worth $287,000 after acquiring an additional 950 shares during the period. Entropy Technologies LP bought a new position in shares of California Water Service Group in the third quarter worth approximately $288,000. Russell Investments Group Ltd. boosted its position in shares of California Water Service Group by 214.8% in the third quarter. Russell Investments Group Ltd. now owns 6,259 shares of the utilities provider’s stock worth $287,000 after purchasing an additional 4,271 shares during the period. Tower Research Capital LLC TRC increased its stake in shares of California Water Service Group by 664.7% in the second quarter. Tower Research Capital LLC TRC now owns 6,286 shares of the utilities provider’s stock worth $286,000 after purchasing an additional 5,464 shares in the last quarter. Finally, Oxford Asset Management LLP purchased a new stake in shares of California Water Service Group in the second quarter worth $234,000. Institutional investors own 82.78% of the company’s stock.

About California Water Service Group (Get Free Report)

California Water Service Group (NYSE: CWT) is a publicly traded holding company that provides regulated water utility services through its subsidiaries. The company delivers safe, reliable drinking water and wastewater management to residential, commercial, industrial and municipal customers across California, Hawaii and New Mexico. Its principal operating units include California Water Service, New Mexico Water Service and Hawaii Water Service, each responsible for end‐to‐end water supply operations—from source development and treatment to distribution and customer service.

Founded in 1926 as the California Water Service Company, the group has grown to become one of the largest investor‐owned water utilities in the United States by customer count.

Featured Stories Five stocks we like better than California Water Service Group Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for California Water Service Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for California Water Service Group and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINESavers Value Village (SVV) Projected to Release Quarterly Earnings on Thursday

Berkshire Builds a Moat Around HomebuildersTaylor Morrison Home NYSE: TMHC stockholders approved the company’s proposed merger agreement with Berkshire Hathaway Inc. during a special meeting held at 8:00 a.m. Pacific Time, according to remarks from company executives at the meeting.

Sheryl Palmer, Taylor Morrison’s chairman and chief executive officer, called the 2026 special meeting of stockholders to order and outlined the proposals presented for a vote. The primary item was the adoption of the agreement and plan of merger dated May 31, 2026, among Taylor Morrison Home Corporation, Berkshire Hathaway Inc. and WXYZ Merger Sub Inc., a wholly owned subsidiary of Berkshire Hathaway.

Get Taylor Morrison Home alerts:

Taylor Morrison: A Home Building Stock You Can Buy at a DiscountUnder the agreement described at the meeting, WXYZ Merger Sub Inc. will merge with and into Taylor Morrison, with Taylor Morrison surviving the merger as a wholly owned subsidiary of Berkshire Hathaway. Palmer said the company’s board of directors unanimously recommended that stockholders vote in favor of the merger proposal.

Stockholders Approve Merger Proposal Todd Merrill, Taylor Morrison’s chief legal officer and secretary, served as secretary and inspector of election for the meeting. Merrill said the board had fixed June 22, 2026, as the record date for stockholders entitled to vote. As of that date, Taylor Morrison had 91,999,956 shares of common stock outstanding and entitled to vote.

KB Home: Building on Strong Foundations During Volatile TimesMerrill also said Broadridge, the company’s mailing and tabulation agent, informed Taylor Morrison that a majority of the voting power of outstanding common stock entitled to vote was present in person or represented by proxy at the meeting.

After the polls closed at 8:07 a.m. Pacific Time, Merrill reported that stockholders had voted in favor of the agreement and plan of merger. Palmer then declared the merger agreement approved.

Executive Compensation Vote Also Passes Stockholders also approved, on a non-binding advisory basis, compensation that may be paid or become payable to Taylor Morrison’s named executive officers in connection with the merger.

Palmer said the board unanimously recommended that stockholders vote for the advisory compensation proposal. Merrill reported that holders of a majority of shares present in person or by proxy and entitled to vote on the matter had voted in favor of the advisory executive compensation proposal.

A third proposal, which would have allowed the company to adjourn the meeting under certain circumstances, was not considered. Palmer said it would not be necessary to take up that proposal.

No Stockholder Questions Submitted During the meeting, stockholders were given the opportunity to submit questions through the web portal regarding the proposals. Palmer said there were no questions on the proposals and no further business before the meeting before moving to the final vote.

The meeting was attended by several members of Taylor Morrison’s board of directors, including Peter Lane, Anne Mariucci, Heather Ostis, Andrea Owen, Denise Warren, Amanda Whalen and Christopher Yip. Curt VanHyfte, the company’s chief financial officer, also attended.

Palmer said the company would report the final vote results in a Form 8-K filing within four business days. The meeting was adjourned following the vote announcements.

About Taylor Morrison Home (NYSE:TMHC)Taylor Morrison Home Corporation NYSE: TMHC is a leading national homebuilder and developer specializing in the design, construction and sale of single-family detached and attached homes. The company's portfolio spans entry-level, first-time, move-up and active-adult segments, offering buyers a diverse array of architectural styles, floor plans and personalized design options. Through its vertically integrated model, Taylor Morrison manages land acquisition, community development, construction and sales to deliver quality homes and customer-focused experiences across its markets.

The company's heritage traces back to Morrison Homes, founded in 1977, and Taylor Woodrow, established in 1921 in the United Kingdom.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Taylor Morrison Home Right Now?Before you consider Taylor Morrison Home, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Taylor Morrison Home wasn't on the list.

While Taylor Morrison Home currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Posted by Defense World Staff on Jul 23rd, 2026

Shares of Freshpet, Inc. (NASDAQ:FRPT – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eighteen ratings firms that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, ten have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $74.25.

A number of research firms recently weighed in on FRPT. Piper Sandler reaffirmed an “overweight” rating on shares of Freshpet in a report on Monday, June 15th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $63.00 price objective on shares of Freshpet in a report on Thursday, May 7th. DA Davidson raised Freshpet to a “strong-buy” rating in a research note on Monday, July 6th. JPMorgan Chase & Co. upgraded Freshpet from a “neutral” rating to an “overweight” rating and increased their target price for the company from $66.00 to $68.00 in a research report on Thursday, May 7th. Finally, Bank of America decreased their target price on Freshpet from $75.00 to $70.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 1st.

View Our Latest Report on Freshpet

Insider Buying and Selling at Freshpet In related news, CEO William B. Cyr sold 42,907 shares of the firm’s stock in a transaction dated Wednesday, May 20th. The shares were sold at an average price of $47.92, for a total value of $2,056,103.44. Following the transaction, the chief executive officer directly owned 204,585 shares of the company’s stock, valued at approximately $9,803,713.20. This trade represents a 17.34% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In the last three months, insiders have bought 4,211 shares of company stock worth $215,027 and have sold 235,262 shares worth $11,664,591. 4.30% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Freshpet Hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. raised its position in shares of Freshpet by 2.5% in the fourth quarter. Vanguard Group Inc. now owns 5,281,833 shares of the company’s stock valued at $321,822,000 after buying an additional 128,499 shares during the last quarter. William Blair Investment Management LLC grew its holdings in shares of Freshpet by 30.9% in the fourth quarter. William Blair Investment Management LLC now owns 1,952,767 shares of the company’s stock valued at $118,982,000 after purchasing an additional 461,444 shares during the period. Impax Asset Management Group plc increased its position in Freshpet by 100.0% during the fourth quarter. Impax Asset Management Group plc now owns 140,000 shares of the company’s stock worth $8,530,000 after purchasing an additional 70,000 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp grew its position in Freshpet by 107.4% in the fourth quarter. Mitsubishi UFJ Trust & Banking Corp now owns 193,584 shares of the company’s stock worth $11,795,000 after acquiring an additional 100,260 shares during the period. Finally, Fortis Group Advisors LLC acquired a new stake in Freshpet during the fourth quarter worth $1,722,000.

Freshpet Trading Down 1.6% Shares of Freshpet stock opened at $57.71 on Thursday. The firm has a 50-day simple moving average of $53.41 and a two-hundred day simple moving average of $62.66. The company has a market cap of $2.84 billion, a P/E ratio of 15.43 and a beta of 1.60. Freshpet has a fifty-two week low of $46.45 and a fifty-two week high of $86.00. The company has a debt-to-equity ratio of 0.34, a quick ratio of 5.26 and a current ratio of 6.18.

About Freshpet (Get Free Report)

Freshpet Inc (NASDAQ: FRPT) is a leading pet food company specializing in fresh, refrigerated meals and treats for dogs and cats. The company’s products are formulated with carefully selected, natural ingredients and are designed to offer a higher level of nutrition and freshness than traditional dry or canned pet foods. Freshpet’s offerings include refrigerated rolls, pâtés and snacks, all of which are sold through the refrigerated section of grocery, mass-market and pet specialty stores.

Freshpet’s product portfolio is built around the concept of fresh, minimally processed recipes that do not require preservatives or artificial colors.

Recommended Stories Five stocks we like better than Freshpet Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Freshpet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Freshpet and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINENavient Corporation (NASDAQ:NAVI) Given Consensus Recommendation of “Reduce” by Analysts

Posted by Defense World Staff on Jul 23rd, 2026

Spectrum Brands Holdings Inc. (NYSE:SPB – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $77.09 and traded as high as $89.45. Spectrum Brands shares last traded at $89.1950, with a volume of 235,650 shares changing hands.

Analyst Ratings Changes Several equities research analysts have weighed in on the stock. Canaccord Genuity Group dropped their price target on shares of Spectrum Brands from $100.00 to $99.00 and set a “buy” rating for the company in a research report on Wednesday, June 17th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $81.00 price objective on shares of Spectrum Brands in a research report on Friday, May 8th. Weiss Ratings raised shares of Spectrum Brands from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, April 24th. Wells Fargo & Company increased their target price on shares of Spectrum Brands from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 8th. Finally, Wall Street Zen cut Spectrum Brands from a “buy” rating to a “hold” rating in a research note on Sunday, June 21st. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Spectrum Brands has an average rating of “Moderate Buy” and a consensus price target of $87.00.

Check Out Our Latest Research Report on SPB

Spectrum Brands Stock Performance The company has a quick ratio of 1.42, a current ratio of 2.29 and a debt-to-equity ratio of 0.30. The company has a market cap of $2.05 billion, a P/E ratio of 17.02, a P/E/G ratio of 2.79 and a beta of 0.64. The business has a fifty day moving average of $82.59 and a 200 day moving average of $77.09.

Spectrum Brands (NYSE:SPB – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.21. Spectrum Brands had a net margin of 4.47% and a return on equity of 8.23%. The business had revenue of $708.90 million for the quarter, compared to analysts’ expectations of $676.45 million. During the same quarter in the previous year, the business posted $0.68 earnings per share. The firm’s revenue for the quarter was up 4.9% compared to the same quarter last year. On average, equities analysts predict that Spectrum Brands Holdings Inc. will post 5.32 EPS for the current year.

Spectrum Brands Announces Dividend The business also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Tuesday, May 26th were paid a dividend of $0.47 per share. The ex-dividend date of this dividend was Tuesday, May 26th. This represents a $1.88 dividend on an annualized basis and a dividend yield of 2.1%. Spectrum Brands’s payout ratio is presently 35.88%.

Insider Activity In related news, CEO David M. Maura purchased 2,500 shares of Spectrum Brands stock in a transaction that occurred on Wednesday, May 20th. The shares were bought at an average price of $72.85 per share, for a total transaction of $182,125.00. Following the completion of the transaction, the chief executive officer directly owned 790,708 shares of the company’s stock, valued at $57,603,077.80. This represents a 0.32% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 4.50% of the stock is owned by corporate insiders.

Institutional Trading of Spectrum Brands Several large investors have recently bought and sold shares of the company. Manning & Napier Advisors LLC lifted its stake in shares of Spectrum Brands by 9.1% in the 4th quarter. Manning & Napier Advisors LLC now owns 300,000 shares of the company’s stock valued at $17,724,000 after purchasing an additional 25,000 shares during the period. Generali Investments CEE investicni spolecnost a.s. grew its stake in Spectrum Brands by 91.7% in the fourth quarter. Generali Investments CEE investicni spolecnost a.s. now owns 47,935 shares of the company’s stock worth $2,832,000 after purchasing an additional 22,935 shares during the period. Gamco Investors INC. ET AL grew its stake in Spectrum Brands by 8.8% in the fourth quarter. Gamco Investors INC. ET AL now owns 354,082 shares of the company’s stock worth $20,919,000 after purchasing an additional 28,569 shares during the period. LSV Asset Management raised its holdings in Spectrum Brands by 2.9% in the fourth quarter. LSV Asset Management now owns 602,980 shares of the company’s stock worth $35,624,000 after purchasing an additional 17,100 shares in the last quarter. Finally, Pacer Advisors Inc. purchased a new position in Spectrum Brands during the fourth quarter valued at $6,242,000.

Spectrum Brands Company Profile (Get Free Report)

Spectrum Brands Holdings, Inc is a global consumer products company that develops and markets a diverse portfolio of branded household and personal care products. Organized into four principal business segments—Hardware & Home Improvement, Home & Garden, Pet, and Appliances & Personal Care—the company offers a broad range of items including security and plumbing solutions, small electric appliances, grooming tools, and pet care accessories. Its hardware division features well-known brands such as Kwikset, Baldwin and Pfister, while the home appliance segment is anchored by names like Russell Hobbs and Remington.

Read More Five stocks we like better than Spectrum Brands Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play Receive News & Ratings for Spectrum Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectrum Brands and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBrookfield Real Assets Income Fund (NYSE:RA) Shares Cross Above 200 Day Moving Average – Here’s Why

NEXT HEADLINE »Tsakos Energy Navigation (NYSE:TEN) Stock Passes Above 200 Day Moving Average – Here’s Why

High-yield dividend stocks tend to be slower-growing companies. However, that's not the case with Kinder Morgan (KMI +0.34%). The natural gas pipeline giant grew adjusted earnings per share by a brisk 32% in the second quarter, driven by robust gas demand. That's providing plenty of support for its 3.7%-yielding dividend.

That strong growth should continue, fueled by rising power demand to support AI data centers and other catalysts. It should give the pipeline stock ample power to continue growing its high-yielding dividend.

Image source: Getty Images.

Robust results Kinder Morgan recently reported its second-quarter results. The gas pipeline giant posted $867 million of net income, a record for the second quarter. Meanwhile, its adjusted earnings rocketed 32% to $0.37 per share.

The company's gas pipeline segment generated nearly $1.5 billion in earnings before depreciation and amortization, up 8.5% from the prior year. Kinder Morgan benefited from a 7% uptick in volumes, driven by liquefied natural gas (LNG) deliveries, increased exports to Mexico, and higher power generation demand. It also benefited from a 17% increase in product pipeline earnings and a 43% surge in carbon dioxide profitability, both largely driven by higher commodity prices.

Today's Change

(

0.34

%) $

0.11

Current Price

$

32.49

Kinder Morgan's strong start to the year has it on track to significantly exceed its budget. The company initially expected to generate $1.37 per share of adjusted earnings this year, up about 8% from last year. It now expects to exceed that budget by 12%. The company's higher earnings are further strengthening its balance sheet. It now expects to end the year with a leverage ratio of 3.6 times, down from its 3.8 times target and at the low end of its target range.

The pipeline company completed $660 million of growth capital projects during the quarter. Notable ones included the Cumberland Project to serve a new gas-fired power plant in Tennessee and the expansion of its Gulf Coast Express pipeline to increase gas flow from the Permian Basin to markets in South Texas. It ended the quarter with a $9.6 billion backlog of expansion projects, down $500 million from the first quarter. However, the company's board recently provided contingent approval for nearly $400 million in additional projects that aren't currently in the backlog, with the bulk supporting power generation and local distribution company demand. These secured projects provide visibility into growth through 2030.

AI power demand is emerging as a major catalyst for gas demand. There are currently 277 gigawatts of power demand from data centers under development in the U.S., representing 42 billion cubic feet per day of potential natural gas capacity to meet peak demand. While developers won't build all that capacity and gas won't be the only power source, it's a meaningful long-term growth driver for Kinder Morgan. It's currently pursuing more than $10 billion of additional gas infrastructure expansion opportunities beyond its current backlog to further enhance and extend its growth profile.

High-powered total return potential Kinder Morgan has increased its high-yielding dividend for nine straight years. That trend seems likely to continue due to surging gas demand from AI power and other catalysts. This growth and income combo should give Kinder Morgan the fuel to generate high-octane total returns, making it a great way to cash in on the AI boom.

Posted by Defense World Staff on Jul 23rd, 2026

Diamondback Energy, Inc. (NASDAQ:FANG – Get Free Report) has been assigned an average recommendation of “Buy” from the twenty-five analysts that are currently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation, seventeen have given a buy recommendation and four have issued a strong buy recommendation on the company. The average 12 month price target among analysts that have covered the stock in the last year is $218.6842.

A number of equities research analysts have commented on the stock. Truist Financial dropped their price objective on shares of Diamondback Energy from $242.00 to $220.00 and set a “buy” rating on the stock in a research report on Thursday, July 16th. Weiss Ratings cut shares of Diamondback Energy from a “hold (c)” rating to a “hold (c-)” rating in a research report on Thursday, July 16th. UBS Group lowered their target price on shares of Diamondback Energy from $246.00 to $243.00 and set a “buy” rating for the company in a research note on Tuesday. Barclays increased their target price on Diamondback Energy from $225.00 to $232.00 and gave the company an “overweight” rating in a report on Tuesday, May 26th. Finally, Raymond James Financial restated a “strong-buy” rating and issued a $249.00 price target on shares of Diamondback Energy in a research note on Wednesday, June 10th.

Get Our Latest Report on FANG

Insiders Place Their Bets In other news, Director Mark Lawrence Plaumann sold 500 shares of the firm’s stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $196.50, for a total transaction of $98,250.00. Following the sale, the director owned 13,437 shares of the company’s stock, valued at approximately $2,640,370.50. This trade represents a 3.59% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Charles Alvin Meloy sold 83,334 shares of the business’s stock in a transaction that occurred on Tuesday, June 16th. The stock was sold at an average price of $187.12, for a total value of $15,593,458.08. Following the sale, the director owned 851,530 shares of the company’s stock, valued at approximately $159,338,293.60. The trade was a 8.91% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 113,691 shares of company stock worth $21,622,752 over the last 90 days. Insiders own 0.64% of the company’s stock.

Institutional Trading of Diamondback Energy Institutional investors have recently modified their holdings of the stock. Mirae Asset Global Investments Co. Ltd. raised its position in Diamondback Energy by 18.3% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 139,308 shares of the oil and natural gas company’s stock worth $20,942,000 after buying an additional 21,575 shares during the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Diamondback Energy by 4.1% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 1,441,622 shares of the oil and natural gas company’s stock worth $216,719,000 after purchasing an additional 56,194 shares in the last quarter. Eagle Global Advisors LLC purchased a new position in Diamondback Energy during the fourth quarter worth about $5,472,000. Hsbc Holdings PLC raised its holdings in Diamondback Energy by 16.3% during the fourth quarter. Hsbc Holdings PLC now owns 338,577 shares of the oil and natural gas company’s stock worth $50,890,000 after purchasing an additional 47,450 shares in the last quarter. Finally, QSM Asset Management Ltd lifted its position in Diamondback Energy by 100.0% in the fourth quarter. QSM Asset Management Ltd now owns 61,000 shares of the oil and natural gas company’s stock valued at $9,170,000 after purchasing an additional 30,500 shares during the period. Hedge funds and other institutional investors own 90.01% of the company’s stock.

Diamondback Energy Stock Performance Shares of FANG opened at $203.02 on Thursday. Diamondback Energy has a 1 year low of $134.30 and a 1 year high of $214.51. The stock has a market capitalization of $57.11 billion, a PE ratio of 236.07 and a beta of 0.42. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.55 and a current ratio of 0.56. The stock has a 50-day simple moving average of $191.29 and a 200-day simple moving average of $182.04.

Diamondback Energy (NASDAQ:FANG – Get Free Report) last issued its earnings results on Monday, May 4th. The oil and natural gas company reported $4.23 earnings per share for the quarter, beating the consensus estimate of $3.74 by $0.49. Diamondback Energy had a net margin of 1.87% and a return on equity of 7.76%. The firm had revenue of $4.24 billion for the quarter, compared to analysts’ expectations of $3.83 billion. During the same quarter last year, the company earned $4.54 earnings per share. The firm’s revenue was up 4.7% compared to the same quarter last year. On average, analysts predict that Diamondback Energy will post 18.9 earnings per share for the current fiscal year.

Diamondback Energy Increases Dividend The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 21st. Stockholders of record on Thursday, May 14th were issued a $1.10 dividend. This represents a $4.40 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Thursday, May 14th. This is an increase from Diamondback Energy’s previous quarterly dividend of $1.05. Diamondback Energy’s dividend payout ratio (DPR) is currently 511.63%.

Diamondback Energy Company Profile (Get Free Report)

Diamondback Energy, Inc (NASDAQ: FANG) is an independent oil and natural gas company focused on the development, exploration and production of unconventional resources in the Permian Basin. Headquartered in Midland, Texas, the company concentrates its operations in the core Midland and Delaware sub‑basins of West Texas and southeastern New Mexico, where it pursues contiguous acreage positions to support repeatable drilling programs.

Diamondback’s activities span the upstream value chain, including leasehold acquisition, well planning, drilling, completion and production optimization.

Featured Stories Five stocks we like better than Diamondback Energy Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Diamondback Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diamondback Energy and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEEastman Chemical Company (NYSE:EMN) Given Consensus Rating of “Moderate Buy” by Analysts

NEXT HEADLINE »Canadian Imperial Bank of Commerce (NYSE:CM) Given Average Rating of “Moderate Buy” by Brokerages

, /PRNewswire/ -- Schall, Brown & Schwartza national shareholder rights litigation firm, reminds investors of a class action lawsuit against AeroVironment, Inc. ("AeroVironment" or "the Company") (NASDAQ: AVAV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

If you purchased AeroVironment, Inc. securities, you may be entitled to compensation without payment of any out-of-pocket fees or costs. Shareholders who purchased shares of AVAV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why SBS: Schall, Brown & Schwartz represents investors around the world, specializing in securities class action lawsuits and shareholder rights litigation. SBS brings together the extensive experience and diverse skill sets of founding partners Brian Schall, Andrew Brown, and David Schwartz. SBS is dedicated to aggressively advocating for every investor.

CLASS PERIOD: June 25, 2025 to March 10, 2026

DEADLINE: July 27, 2026

Details of the Case: According to the Complaint, the Company made false and misleading statements to the market. AeroVironment downplayed the threat of competition related to its work with the U.S. Space Force's Satellite Communication Augmentation Resource ("SCAR") program. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about AeroVironment, investors suffered damages.

If you are a shareholder who suffered a loss, click here to participate.

We encourage investors to contact Adam Rosen and David Schwartz of Schall, Brown & Schwartz, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Join the case to recover your losses

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

Schall, Brown & Schwartz

Brian Schall, Esq.,

Andrew Brown, Esq.,

David Schwartz, Esq.,

www.schallfirm.com

Office: 310-301-3335

[email protected]

SOURCE Schall, Brown & Schwartz LLP

AMSTERDAM and PHILADELPHIA, July 23, 2026 (GLOBE NEWSWIRE) -- Akzo Nobel N.V. (“AkzoNobel”) and Axalta Coating Systems Ltd. (“Axalta”) today announced enhancements to the proposed governance arrangements for the combined company following completion of their pending merger of equals.

Since announcing the proposed all-share merger of equals and convening of the AkzoNobel EGM and Axalta SGM, AkzoNobel and Axalta have engaged extensively with shareholders and other stakeholders on the governance of the combined company. That dialogue has led to the following refinements:

Annual re-election of all Directors following the initial three-year period after completion (previously contemplated following a five-year period after completion); andApproval threshold applicable during the initial three-year period after completion of two-thirds of Non-Executive Directors (previously contemplated as 75%) for (i) any proposal to the general meeting regarding the appointment and dismissal of Directors, (ii) the appointment and removal of the CEO, Deputy CEO and CFO, (iii) designation of the Chair and Vice Chair titles and (iv) amendments to the remuneration policy. Rakesh Sachdev, Chair of the Axalta Board of Directors, stated, “We are pleased to announce these governance enhancements following constructive engagement with our shareholders. We believe these changes reinforce our commitment to strong corporate governance and effective Board oversight while further strengthening the governance framework of the combined company. We appreciate the feedback we've received throughout this process and remain confident that this combination will create a premier global coatings company that delivers significant long-term value for all shareholders.”

Ben Noteboom, Chairman of the Supervisory Board of AkzoNobel, said: “We have listened thoughtfully to our shareholders and believe these changes reflect the spirit of partnership and accountability that will define the combined company from day one. We are grateful for the constructive engagement that has shaped these improvements, which further align the governance of the combined company with the interests of all shareholders and other stakeholders.”

These governance enhancements do not require any changes to the proposed Articles of Association of the combined company. As a result, the AkzoNobel EGM and Axalta SGM planned for August 5, 2026 are proceeding as planned, with the existing agenda items unaffected.

This is a public announcement by Akzo Nobel N.V. and Axalta pursuant to section 17 paragraph 1 of the European Market Abuse Regulation (596/2014).

About AkzoNobel
Since 1792, we’ve been supplying the innovative paints and coatings that help to color people’s lives and protect what matters most. Our world class portfolio of brands – including Dulux, International, Sikkens and Interpon – is trusted by customers around the globe. We’re active in more than 150 countries and use our expertise to sustain and enhance everyday life. Because we believe every surface is an opportunity. It’s what you’d expect from a pioneering and long-established paints company that’s dedicated to providing more sustainable solutions and preserving the best of what we have today – while creating an even better tomorrow. Let’s paint the future together.

About Axalta
Axalta is a global leader in the coatings industry, providing customers with innovative, colorful, beautiful and sustainable coatings solutions. From light vehicles, commercial vehicles and refinish applications to electric motors, building facades and other industrial applications, our coatings are designed to prevent corrosion, increase productivity and enhance durability. With more than 150 years of experience in the coatings industry, the global team at Axalta continues to find ways to serve our more than 100,000 customers in over 140 countries better every day with the finest coatings, application systems and technology. For more information visit axalta.com and follow us on LinkedIn.

Not for publication – for more information AkzoNobel Media Relations

AkzoNobel Investor RelationsT +31 (0)88 - 969 7833
Contact: Diana Abrahams
[email protected] +31 (0)88 - 969 0139
Contact: Jan Willem Enhus
[email protected]  Axalta Media RelationsAxalta Investor RelationsT +31 (0)88 - 969 7833
Contact: Patricia Morschel
[email protected] +1 (610) 999-9407
Contact: Colleen Lubic
[email protected]   Safe Harbor Statement

This media release contains statements which address such key issues as AkzoNobel’s growth strategy, future financial results, market positions, product development, products in the pipeline and product approvals. Such statements should be carefully considered, and it should be understood that many factors could cause forecast and actual results to differ from these statements. These factors include, but are not limited to, price fluctuations, currency fluctuations, developments in raw material and personnel costs, pensions, physical and environmental risks, legal issues, and legislative, fiscal, and other regulatory measures, as well as significant market disruptions. Stated competitive positions are based on management estimates supported by information provided by specialized external agencies. For a more comprehensive discussion of the risk factors affecting our business, please see our latest annual report.

Important Information Regarding the Proposed Axalta Transaction
General Restrictions
This communication is not for release, publication, or distribution, in whole or in part, in or into, directly or indirectly, any jurisdiction in which such release, publication, or distribution would be unlawful.

This communication is not a prospectus and the information in this communication is not intended to be complete. This communication is for informational purposes only and is not intended to be and shall not constitute a solicitation of any vote or approval, or an offer to buy or sell, or the solicitation of an offer to buy or sell, any securities, or an invitation or recommendation to subscribe for, acquire or buy securities of AkzoNobel or Axalta or any other financial products or securities, in any place or jurisdiction, nor shall there be any offer, solicitation or sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended (the “Securities Act”).

Any decision to purchase, subscribe for, otherwise acquire, sell or otherwise dispose of any securities must be made only on the basis of the information contained in and incorporated by reference into the prospectus with respect to the shares to be allotted by AkzoNobel in the proposed transaction, which was published on June 24, 2026. 

The distribution of this communication may, in some countries, be restricted by law or regulation. Accordingly, persons who come into possession of this document should inform themselves of and observe these restrictions. To the fullest extent permitted by applicable law, AkzoNobel and Axalta disclaim any responsibility or liability for the violation of any such restrictions by any person. Neither AkzoNobel, nor Axalta, nor any of their advisors assume any responsibility for any violation by any person of any of these restrictions. Shareholders of AkzoNobel and Axalta, respectively, with any doubt as to their position should consult an appropriate professional advisor without delay.

This communication is addressed to and directed only at, persons who are outside the United Kingdom or, in the United Kingdom, at persons who are: (i) persons having professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”), (ii) persons falling within Article 49(2)(a) to (d) of the Order, or (iii) persons to whom it may otherwise lawfully be communicated pursuant to the Order (all such persons together being referred to as, “Relevant Persons”). This communication is directed only at Relevant Persons. Other persons should not act or rely on this communication or any of its contents.   Any investment or investment activity to which this communication relates is available only to Relevant Persons and will be engaged in only with such persons. Solicitations resulting from this communication will only be responded to if the person concerned is a Relevant Person.

Additional Information and Where To Find It
In connection with the proposed transaction between AkzoNobel and Axalta, AkzoNobel filed with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement on Form F-4 on May 27, 2026, as amended on June 18, 2026, which included a proxy statement of Axalta that also constitutes a prospectus with respect to the shares to be offered by AkzoNobel in the proposed transaction. The registration statement was declared effective by the SEC on June 23, 2026. In connection with the proposed transaction, on June 24, 2026, Axalta filed with the SEC a definitive proxy statement and, on or about June 24, 2026, Axalta commenced mailing the definitive proxy statement to its holders of record as of June 11, 2026. Each of AkzoNobel and Axalta will also file other relevant documents in connection with the proposed transaction. This communication is not a substitute for any registration statement, proxy statement/prospectus or other documents AkzoNobel and/or Axalta may file with the SEC or any other competent regulator in connection with the proposed transaction. This communication does not contain all the information that should be considered concerning the proposed transaction and is not intended to form the basis of any investment decision or any other decision in respect of the proposed transaction. BEFORE MAKING ANY VOTING OR INVESTMENT DECISIONS, INVESTORS, STOCKHOLDERS AND SHAREHOLDERS OF AKZONOBEL AND AXALTA ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THE PROXY STATEMENT/PROSPECTUS, AS APPLICABLE, AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, IN CONNECTION WITH THE PROPOSED TRANSACTION WHEN THEY BECOME AVAILABLE, AS THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT AKZONOBEL, AXALTA, THE PROPOSED TRANSACTION AND RELATED MATTERS. The registration statement and proxy statement/prospectus and other relevant documents filed by AkzoNobel and Axalta with the SEC are available free of charge at the SEC’s website at www.sec.gov. In addition, investors and shareholders are able to obtain free copies of the proxy statement/prospectus and other documents filed with the SEC from Axalta’s investor relations webpage at https://ir.axalta.com/sec-filings/all-sec-filings or from AkzoNobel’s investor relations webpage at https://www.akzonobel.com/en/investors/all-sec-filings.

The contents of this communication should not be construed as financial, legal, business, investment, tax or other professional advice. Each recipient should consult with its own professional advisors for any such matter and advice.

Participants in the Solicitation
This communication is not a solicitation of proxies in connection with the proposed transaction. However, under SEC rules, AkzoNobel, Axalta and certain of their respective directors and executive officers and other members of their respective management and employees may be deemed to be participants in the solicitation of proxies in connection with the proposed transaction. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of proxies in connection with the proposed transaction, including a description of their direct or indirect interests in the proposed transaction, by security holdings or otherwise, is set forth in the definitive proxy statement/prospectus relating to the proposed transaction, which was filed with the SEC on June 24, 2026. Information about AkzoNobel’s supervisory board members and members of the board of management is set forth in AkzoNobel’s latest annual report, as filed with the AFM, the Dutch trade register and on its website at https://www.akzonobel.com/en/investors/results-center, and as updated from time to time via filings made by AkzoNobel with the AFM. Additional information regarding the interests of persons who may, under the rules of the SEC, be deemed participants in the solicitation of Axalta security holders in connection with the proposed transaction, which may, in some cases, be different than those of Axalta’s shareholders generally, including a description of their direct or indirect interests, by security holdings or otherwise, will be set forth in the proxy statement/prospectus and other relevant materials when they are filed with the SEC. These documents can be obtained free of charge from the sources indicated above.

Cautionary Statement Concerning Forward-Looking Statements
This communication contains forward-looking statements as that term is defined in Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995, regarding, among other things, statements about management’s expectations of AkzoNobel’s and Axalta’s future operating and financial performance, product development, market position, and business strategy. Such forward-looking statements can sometimes be identified by the use of forward-looking terms such as “believes,” “expects,” “may,” “will,” “shall,” “should,” “would,” “could,” “potential,” “seeks,” “aims,” “projects,” “predicts,” “is optimistic,” “intends,” “plans,” “estimates,” “targets,” “anticipates,” “continues” or other comparable terms or negatives of these terms, but not all forward-looking statements include such identifying words. You are cautioned not to rely on these forward-looking statements. Forward-looking statements are based upon current plans, estimates and expectations that are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. We can give no assurance that such plans, estimates or expectations will be achieved and therefore, actual results may differ materially from any plans, estimates or expectations in such forward-looking statements. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include: a condition to the closing of the proposed transaction may not be satisfied; the occurrence of any event that can give rise to termination of the proposed transaction; a regulatory approval that may be required for the proposed transaction is delayed, is not obtained or is obtained subject to conditions that are not anticipated; AkzoNobel and Axalta are unable to achieve the synergies and value creation contemplated by the proposed transaction; AkzoNobel and Axalta are unable to promptly and effectively integrate their businesses; management’s time and attention is diverted on transaction related issues; the possibility that competing offers or acquisition proposals may be made; disruption from the proposed transaction makes it more difficult to maintain business, contractual and operational relationships; the credit ratings of AkzoNobel or Axalta decline following the proposed transaction; legal proceedings are instituted against AkzoNobel or Axalta, including resulting expense or delay; AkzoNobel or Axalta is unable to retain or hire key personnel; the communication or the consummation of the proposed acquisition has a negative effect on the market price of the capital stock of AkzoNobel or Axalta or on AkzoNobel’s or Axalta’s operating results; evolving legal, regulatory and tax regimes; changes in economic, financial, political and regulatory conditions, in the Netherlands, the United States and elsewhere, and other factors that contribute to uncertainty and volatility, natural and man-made disasters, civil unrest, pandemics (e.g., the coronavirus (COVID-19) pandemic), geopolitical uncertainty, and conditions that may result from legislative, regulatory, trade and policy changes associated with the current or subsequent United States or Netherlands administration; the ability of AkzoNobel or Axalta to successfully recover from a disaster or other business continuity problem due to a hurricane, flood, earthquake, terrorist attack, war, pandemic, security breach, cyber-attack, power loss, telecommunications failure or other natural or man-made event, including the ability to function remotely during long-term disruptions; the impact of public health crises, such as pandemics and epidemics and any related company or governmental policies and actions to protect the health and safety of individuals or governmental policies or actions to maintain the functioning of national or global economies and markets, including any quarantine, “shelter in place,” “stay at home,” workforce reduction, social distancing, shut down or similar actions and policies; actions by third parties, including government agencies; the risk that disruptions from the proposed transaction will harm AkzoNobel’s or Axalta’s business, including current plans and operations and/or divert management’s attention from AkzoNobel’s or Axalta’s ongoing business operations; certain restrictions during the pendency of the acquisition that may impact AkzoNobel’s or Axalta’s ability to pursue certain business opportunities or strategic transactions; AkzoNobel’s or Axalta’s ability to meet expectations regarding the accounting and tax treatments of the proposed transaction; the risks and uncertainties discussed in AkzoNobel’s latest annual report as filed with the AFM, the Dutch trade register and on its website at https://www.akzonobel.com/en/investors/results-center; and the risks and uncertainties discussed in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in Axalta’s reports filed with the SEC. These risks, as well as other risks associated with the proposed transaction, are more fully discussed in the proxy statement/prospectus. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. We caution you not to place undue reliance on any of these forward-looking statements as they are not guarantees of future performance or outcomes and that actual performance and outcomes, including, without limitation, our actual results of operations, financial condition and liquidity, and the development of new markets or market segments in which we operate, may differ materially from those made in or suggested by the forward-looking statements contained in this communication. Except as required by law, neither AkzoNobel nor Axalta assumes any obligation to update or revise the information contained herein, which speaks only as of the date hereof.

Posted by Defense World Staff on Jul 23rd, 2026

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has received an average recommendation of “Moderate Buy” from the fourteen ratings firms that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and ten have assigned a buy rating to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $46.8462.

Several research firms have weighed in on BEAM. Tudor Pickering set a $39.00 target price on shares of Beam Therapeutics in a report on Wednesday, May 13th. HC Wainwright reaffirmed a “buy” rating and issued a $80.00 price target on shares of Beam Therapeutics in a report on Tuesday, July 7th. Sanford C. Bernstein lowered their price target on shares of Beam Therapeutics from $40.00 to $39.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 13th. Citigroup raised their price objective on shares of Beam Therapeutics from $64.00 to $68.00 and gave the stock a “buy” rating in a research note on Thursday, March 26th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Beam Therapeutics in a research report on Friday, July 17th.

View Our Latest Report on Beam Therapeutics

Beam Therapeutics Stock Down 2.4% Beam Therapeutics stock opened at $26.64 on Thursday. Beam Therapeutics has a fifty-two week low of $15.60 and a fifty-two week high of $38.26. The firm has a market capitalization of $2.74 billion, a price-to-earnings ratio of -39.18 and a beta of 2.18. The stock’s fifty day moving average is $31.28 and its two-hundred day moving average is $29.30. The company has a debt-to-equity ratio of 0.09, a quick ratio of 16.99 and a current ratio of 16.99.

Beam Therapeutics (NASDAQ:BEAM – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.91) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.03) by $0.12. Beam Therapeutics had a negative return on equity of 29.00% and a negative net margin of 39.66%.The business had revenue of $31.74 million during the quarter, compared to the consensus estimate of $10.98 million. During the same quarter in the previous year, the company posted ($1.23) EPS. The business’s revenue was up 323.2% on a year-over-year basis. Analysts predict that Beam Therapeutics will post -4.16 EPS for the current fiscal year.

Insider Buying and Selling In other Beam Therapeutics news, insider Fmr Llc sold 251,488 shares of the stock in a transaction on Friday, June 26th. The stock was sold at an average price of $35.26, for a total transaction of $8,867,466.88. Following the sale, the insider owned 854,583 shares in the company, valued at approximately $30,132,596.58. This represents a 22.74% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 3.80% of the company’s stock.

Institutional Trading of Beam Therapeutics Institutional investors and hedge funds have recently made changes to their positions in the stock. CWM LLC grew its holdings in shares of Beam Therapeutics by 15.4% during the fourth quarter. CWM LLC now owns 2,466 shares of the company’s stock worth $68,000 after buying an additional 329 shares in the last quarter. Wealth Effects LLC lifted its stake in shares of Beam Therapeutics by 4.3% during the fourth quarter. Wealth Effects LLC now owns 9,600 shares of the company’s stock valued at $266,000 after buying an additional 400 shares during the period. Franklin Resources Inc. lifted its stake in shares of Beam Therapeutics by 2.6% during the fourth quarter. Franklin Resources Inc. now owns 21,948 shares of the company’s stock valued at $608,000 after buying an additional 566 shares during the period. Van ECK Associates Corp boosted its position in Beam Therapeutics by 48.7% during the third quarter. Van ECK Associates Corp now owns 2,158 shares of the company’s stock worth $52,000 after acquiring an additional 707 shares during the last quarter. Finally, Stifel Financial Corp boosted its position in Beam Therapeutics by 7.8% during the fourth quarter. Stifel Financial Corp now owns 13,405 shares of the company’s stock worth $372,000 after acquiring an additional 965 shares during the last quarter. 99.68% of the stock is currently owned by hedge funds and other institutional investors.

About Beam Therapeutics (Get Free Report)

Beam Therapeutics, Inc (NASDAQ: BEAM) is a biotechnology company dedicated to developing precision genetic medicines through its pioneering base editing platform. Headquartered in Cambridge, Massachusetts, with additional research facilities in Philadelphia, the company focuses on engineering molecular editors capable of making precise single-nucleotide changes in DNA. By harnessing its proprietary base editing technology, Beam aims to correct or disrupt disease-causing genetic variants at their source, offering the potential for novel therapies in areas with significant unmet medical need.

Founded in 2017 as a spin-out from Harvard University and the Broad and Whitehead Institutes, Beam was co-founded by leading academic researcher David R.

Featured Stories Five stocks we like better than Beam Therapeutics Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Beam Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beam Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEMercury Systems Inc (NASDAQ:MRCY) Given Average Rating of “Moderate Buy” by Analysts

NEXT HEADLINE »Edison International (NYSE:EIX) Receives Consensus Recommendation of “Hold” from Brokerages

Equinix, Inc. (NASDAQ:EQIX – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-six brokerages that are covering the company, MarketBeat reports. Five equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and three have issued a strong buy rating on the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $1,153.7917.

A number of equities analysts have recently commented on the stock. Citigroup lifted their target price on shares of Equinix from $1,240.00 to $1,260.00 and gave the company a “buy” rating in a report on Monday, June 29th. Raymond James Financial upgraded shares of Equinix from a “market perform” rating to a “strong-buy” rating and set a $1,250.00 price target for the company in a research note on Thursday, April 30th. Weiss Ratings raised shares of Equinix from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, July 8th. Cantor Fitzgerald lifted their price objective on shares of Equinix from $1,173.00 to $1,186.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Finally, Mizuho upped their target price on shares of Equinix from $1,165.00 to $1,200.00 and gave the company an “outperform” rating in a report on Thursday, May 7th.

View Our Latest Stock Analysis on EQIX

Equinix Stock Up 0.1% Shares of NASDAQ EQIX opened at $1,028.74 on Thursday. The business has a 50-day moving average price of $1,057.27 and a 200 day moving average price of $983.75. The stock has a market cap of $101.45 billion, a PE ratio of 71.19, a price-to-earnings-growth ratio of 1.91 and a beta of 0.98. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.39. Equinix has a 52-week low of $720.62 and a 52-week high of $1,128.68.

Equinix (NASDAQ:EQIX – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The financial services provider reported $10.79 EPS for the quarter, topping the consensus estimate of $4.30 by $6.49. Equinix had a return on equity of 10.03% and a net margin of 15.07%.The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.52 billion. During the same quarter in the previous year, the company posted $9.67 earnings per share. The firm’s revenue was up 9.8% compared to the same quarter last year. Equinix has set its FY 2026 guidance at 42.310-43.110 EPS. Equities research analysts forecast that Equinix will post 38.25 earnings per share for the current year.

Equinix Announces Dividend The business also recently declared a quarterly dividend, which was paid on Wednesday, June 17th. Investors of record on Wednesday, May 20th were issued a dividend of $5.16 per share. The ex-dividend date of this dividend was Wednesday, May 20th. This represents a $20.64 dividend on an annualized basis and a dividend yield of 2.0%. Equinix’s dividend payout ratio (DPR) is currently 142.84%.

Insider Buying and Selling In other news, Chairman Charles J. Meyers sold 5,224 shares of the business’s stock in a transaction that occurred on Wednesday, May 6th. The stock was sold at an average price of $1,085.23, for a total value of $5,669,241.52. Following the transaction, the chairman owned 7,370 shares of the company’s stock, valued at approximately $7,998,145.10. The trade was a 41.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Christopher B. Paisley sold 125 shares of the company’s stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $1,060.29, for a total value of $132,536.25. Following the sale, the director owned 17,557 shares of the company’s stock, valued at $18,615,511.53. This trade represents a 0.71% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 11,115 shares of company stock worth $12,022,574. Insiders own 0.27% of the company’s stock.

Institutional Trading of Equinix Hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. raised its holdings in Equinix by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 13,398,906 shares of the financial services provider’s stock worth $10,265,706,000 after purchasing an additional 107,227 shares in the last quarter. Cohen & Steers Inc. boosted its holdings in Equinix by 23.3% in the 4th quarter. Cohen & Steers Inc. now owns 2,609,011 shares of the financial services provider’s stock valued at $1,998,978,000 after purchasing an additional 493,141 shares in the last quarter. Geode Capital Management LLC increased its position in Equinix by 1.0% during the 4th quarter. Geode Capital Management LLC now owns 2,567,830 shares of the financial services provider’s stock worth $1,959,731,000 after purchasing an additional 25,383 shares during the period. Principal Financial Group Inc. increased its position in Equinix by 1.4% during the 1st quarter. Principal Financial Group Inc. now owns 1,980,497 shares of the financial services provider’s stock worth $1,941,377,000 after purchasing an additional 27,643 shares during the period. Finally, Northern Trust Corp raised its stake in shares of Equinix by 0.6% during the 4th quarter. Northern Trust Corp now owns 1,500,506 shares of the financial services provider’s stock worth $1,149,628,000 after buying an additional 9,614 shares in the last quarter. Hedge funds and other institutional investors own 94.94% of the company’s stock.

About Equinix (Get Free Report)

Equinix, Inc is a global provider of digital infrastructure and interconnection services, specializing in carrier-neutral data centers and colocation. The company operates a platform that enables enterprises, cloud and network service providers, and content companies to colocate IT infrastructure, interconnect directly with partners and providers, and access cloud on-ramps and network services in a secure, low-latency environment.

Equinix’s offerings include traditional colocation space and power, cross-connects and meet-me rooms, and a suite of connectivity and on-demand services designed for hybrid multicloud architectures.

See Also Five stocks we like better than Equinix Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Equinix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equinix and related companies with MarketBeat.com's FREE daily email newsletter.

Posted by Defense World Staff on Jul 23rd, 2026

Ballard Power Systems, Inc. (NASDAQ:BLDP – Get Free Report) (TSE:BLD) has been given a consensus recommendation of “Reduce” by the fifteen brokerages that are presently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating on the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $3.5250.

BLDP has been the subject of a number of recent research reports. Lake Street Capital upgraded Ballard Power Systems from a “hold” rating to a “buy” rating and increased their price objective for the company from $3.00 to $5.00 in a research report on Tuesday, May 5th. Weiss Ratings restated a “sell (d-)” rating on shares of Ballard Power Systems in a report on Friday, July 17th. Raymond James Financial boosted their target price on Ballard Power Systems from $2.40 to $4.00 and gave the stock a “market perform” rating in a research report on Wednesday, May 6th. National Bank Financial set a $4.75 target price on Ballard Power Systems and gave the company a “sector perform” rating in a report on Wednesday, June 24th. Finally, BMO Capital Markets increased their price target on Ballard Power Systems from $1.70 to $2.10 and gave the company an “underperform” rating in a research report on Wednesday, May 6th.

Check Out Our Latest Stock Report on Ballard Power Systems

Institutional Trading of Ballard Power Systems A number of hedge funds have recently bought and sold shares of BLDP. Rockefeller Capital Management L.P. increased its position in shares of Ballard Power Systems by 228.1% in the fourth quarter. Rockefeller Capital Management L.P. now owns 10,000 shares of the technology company’s stock worth $25,000 after acquiring an additional 6,952 shares in the last quarter. Swiss Life Asset Management Ltd purchased a new stake in shares of Ballard Power Systems in the 4th quarter valued at approximately $26,000. Ground Swell Capital LLC acquired a new position in Ballard Power Systems in the 1st quarter worth approximately $26,000. Intesa Sanpaolo S.p.A. acquired a new position in Ballard Power Systems in the 4th quarter worth approximately $28,000. Finally, Cetera Investment Advisers purchased a new position in Ballard Power Systems during the 1st quarter worth approximately $33,000. 28.02% of the stock is owned by hedge funds and other institutional investors.

Ballard Power Systems Stock Up 4.7% NASDAQ BLDP opened at $3.10 on Thursday. Ballard Power Systems has a 12 month low of $1.70 and a 12 month high of $6.57. The company has a market capitalization of $934.59 million, a P/E ratio of -11.48 and a beta of 2.25. The company’s 50 day simple moving average is $4.28 and its 200 day simple moving average is $3.23. The company has a debt-to-equity ratio of 0.03, a current ratio of 10.70 and a quick ratio of 9.90.

Ballard Power Systems (NASDAQ:BLDP – Get Free Report) (TSE:BLD) last issued its earnings results on Tuesday, May 5th. The technology company reported ($0.04) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.02. The firm had revenue of $18.98 million during the quarter, compared to analysts’ expectations of $19.88 million. Ballard Power Systems had a negative net margin of 78.60% and a negative return on equity of 13.48%. Equities research analysts expect that Ballard Power Systems will post -0.16 earnings per share for the current fiscal year.

Ballard Power Systems Company Profile (Get Free Report)

Ballard Power Systems (NASDAQ:BLDP) is a Canadian technology company specializing in the development and manufacture of proton exchange membrane (PEM) fuel cell products. Headquartered in Vancouver, British Columbia, Ballard designs and sells fuel cell stacks and modules that enable zero-emission power generation for a variety of applications, including heavy-duty motive systems, backup power, material handling equipment, and portable power solutions.

Since its founding in 1979, Ballard has built a strong intellectual property portfolio and a track record of innovation in PEM fuel cell technology.

Further Reading Five stocks we like better than Ballard Power Systems Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Ballard Power Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ballard Power Systems and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEDine Brands Global, Inc. (NYSE:DIN) Given Consensus Recommendation of “Hold” by Analysts

NEXT HEADLINE »Criteo S.A. (NASDAQ:CRTO) Given Average Rating of “Moderate Buy” by Analysts

DigitalOcean (DOCN +4.80%) is currently building artificial intelligence (AI) data centers as fast as it can to meet soaring demand for computing capacity from its customers, many of which are small and medium-sized businesses (SMBs). The company's revenue growth is accelerating, which has fueled a staggering 360% increase in its stock over the last 12 months.

DigitalOcean will release its operating results for the second quarter on Aug. 4, and they could determine whether the stock's upward momentum continues. Should investors be buying at the current price?

Image source: Getty Images.

Demand is off the charts for DigitalOcean's AI data centers The cloud computing industry is dominated by trillion-dollar companies like Amazon and Microsoft, but those giants typically chase the customers with the highest spending potential. That leaves SMBs somewhat underserved, but DigitalOcean has filled this gap in the market by offering those smaller companies affordable cloud services with highly personalized support and a simple interface for ease of use.

It is applying that same blueprint to its new platform, which it calls AI-Native Cloud. It features five distinct layers to help DigitalOcean customers develop and deploy AI software. The foundational layer is infrastructure, which includes 20 data centers (and growing) housing thousands of the latest chips from suppliers like Nvidia and Advanced Micro Devices.

Businesses can rent computing capacity from those data centers through AI-Native Cloud, and the platform's other four layers provide the tools to develop usable AI software. Those tools include ready-made large language models (LLMs) from companies like Anthropic, which can serve as the foundation for powerful AI chatbots and AI agents.

On July 7, DigitalOcean announced that it ended Q2 with a whopping $800 million in remaining performance obligations (RPO), which was a tenfold increase from the year-ago period. RPO is usually defined as the value of signed contracts for services that haven't been delivered yet, so this metric can be a good predictor of future revenue. Simply put, it appears several DigitalOcean customers are lining up to rent more data center capacity from the company once it comes online.

Today's Change

(

4.80

%) $

6.55

Current Price

$

143.00

The upcoming Aug. 4 report could be another blockbuster DigitalOcean generated $257.9 million in revenue during Q1, which was a 22% increase from the prior-year period. It was the third straight quarter in which that growth rate accelerated, and based on the company's July 7 update, revenue apparently soared at an even faster rate of 29% during Q2.

DigitalOcean also ended Q1 with a record $1.03 billion in annual run-rate revenue (ARR). AI customers accounted for $170 million of that total, up by a staggering 221% year over year. I would expect the company to report a similarly strong AI result on Aug. 4.

Guidance will be another key point of focus for Wall Street. The company previously said it expects to deliver overall revenue growth of 50% during 2027, but in its recent update, management told investors it plans to revise that forecast higher in the Q2 report because the business is carrying so much momentum.

Should investors buy DigitalOcean stock right now? DigitalOcean is firing on all cylinders right now, but there is a hitch for investors considering adding this stock to their portfolio today. It's trading at a price-to-sales (P/S) ratio of 15.4, which is significantly higher than its long-term average of 8.5 since going public in 2021.

However, based on DigitalOcean's 2027 revenue guidance, its forward P/S ratio is just 8.1. This is where the Aug. 4 report could be important. If management meaningfully revises the company's 2027 revenue growth forecast higher, then its forward P/S ratio might actually be much lower than 8.1. If that's the case, the stock might actually be cheap right now for any investors willing to hold it for at least the next 18 months.

DOCN PS Ratio data by YCharts.

DigitalOcean stock may be up by 360% over the last 12 months, but it's down 25% from its recent peak. This dip might be a good buying opportunity heading into the Aug. 4 report, but investors who add it now must be willing to hold the stock over at least the medium term -- but the longer the better -- to maximize their chances of positive returns.

23.7.2026 09:38

Český stát by podle vyjádření premiéra Andreje Babiše mohl uvést akcie pražského letiště na pražskou burzu v roce 2028. Stát by si i přes vstup Letiště Praha na pražskou burzu ponechal majoritní podíl.

Společnost Letiště Praha zvýšila v minulém roce čistý zisk meziročně o 800 milionů na 3,2 miliardy Kč. Zisk EBITDA zaznamenal také meziroční růst o 800 milionů Kč na 5,1 miliardy Kč.

Zdroj: ČT24

Jakub Němec
Fio banka, a.s.
Prohlášení

23.7.2026 08:57

Před asijsko-pacifické regiony uzavřely čtvrteční seanci v zelených číslech. Dařilo se především technologickým společnostem s expozicí na umělou inteligenci, když společnost Alphabet oznámila navýšení výhledu kapitálových výdajů. Největší růst zaznamenal jihokorejský Kospi (+4,0 %), který je vysoce koncentrován technologickými akciemi.

V Jižní Koreji byl reportován růst HDP, který ve 2Q meziročně vzrostl o 3,7 % při očekávání 3,5 %. V Austrálii byla zveřejněna červnová míra nezaměstnanosti, která dosáhla podle očekávání 4,4 %.

Japonský Nikkei 225 +0,46 % na 66422,6 b.
Hongkongský Hang Seng +1,23 % na 25197,74 b.
Čínský Shanghai Composite +0,22 % na 3875,4557 b.
Jihokorejský Kospi +4,4 % na 7096,89 b.
Australský S&P/ASX 200 +0,18 % na 8839 b.

Zdroj: Bloomberg

Jakub Němec
Fio banka, a.s.
Prohlášení

In June, the initial public offering (IPO) of Space Exploration Technologies (SPCX -6.66%) turned what seemed like a simple IPO into a reminder of how rule changes can reshape your portfolio. If you own an index fund, your portfolio may have been affected by new rules surrounding the IPO, even if you don't own SpaceX.

It all depends on which index funds you hold.

Image source: Getty Images.

What happened Whenever a company is added to a major index, every fund that tracks that index must buy it to stay in line with the benchmark, regardless of price. And that's precisely what happened as the Nasdaq-100 and Russell 1000 each changed their rules to fast-track the inclusion of SpaceX and other major IPOs that are expected this year.

S&P Dow Jones Indices, which maintains the S&P 500, chose not to change its rules, but index funds that follow the Nasdaq-100 and Russell 1000 had to make room for SpaceX by selling a sliver of every existing security or asset. As fund managers worked to remain aligned with their indexes, giants like Apple, Microsoft, and Nvidia were trimmed. The results have been subtle but represent a very real shift in the risk and sector weights for millions of investors' portfolios.

Today's Change

(

-6.66

%) $

-8.23

Current Price

$

115.31

The way both Nasdaq and Russell changed their rules to allow the mega IPO to enter sooner than usual -- rather than wait months or years for inclusion -- is what makes this moment stand out. The move concentrates a bundle of forced buying into a short window, quickly turning passive strategies into an active bet on a single, high-profile listing.

The potential implications SpaceX's share price to date has been volatile, but that doesn't mean losses are inevitable. The fact that some of the world's largest financial firms and venture capitalists are betting on it may enhance the company's resilience to economic downturns and market fluctuations, making it a stable investment with plenty of room to grow. In other words, those who own an index fund or ETF that includes SpaceX could see their portfolios grow enough to more than offset the trimming of other market giants.

S&P's decision not to change its rules could lead to missed gains if SpaceX appreciates dramatically. On the other hand, it might just protect them from loss. Only time will tell.

In the meantime, SpaceX's debut serves as a reminder that high-profile IPOs don't just affect the new stock. They also alter every portfolio holding an index that welcomes them.

Dana George has positions in Apple. The Motley Fool has positions in and recommends Apple, Microsoft, and Nvidia. The Motley Fool has a disclosure policy.

Record Q2 Deliveries: Achieved record deliveries globally with sequential growth in the Americas (60%), APAC (27%), and EMEA (12%).Model Y Performance: Set rec

Microsoft is upgraded from Hold to Buy after a significant pullback, improving risk-reward and making valuations more attractive. MSFT's CapEx surge—expected to exceed $40B in Q4 and $190B for the year—remains the central tension but is justified by robust Azure and AI-driven growth. Azure's 39–40% growth and a massive backlog are critical to converting CapEx into future revenue, supporting the long-term rerating thesis toward $500.

AMD (AMD +1.48%) is making excellent progress in gaining market share in the data center industry.

*Stock prices used were the afternoon prices of July 20, 2026. The video was published on July 22, 2026.

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices. The Motley Fool has a disclosure policy.Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.